Comparative analysis of gene and disease selection in genomic newborn screening studies
Journal of Inherited Metabolic Disease · 2024-09 · 47 (5) · 945-970
DOI: 10.1002/jimd.12750 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 16.05.2024. Verfasst von Isabel R Betzler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Heidelberg University and University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Neonatal Screening. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Genomic newborn screening (gNBS) is on the horizon given the decreasing costs of sequencing and the advanced understanding of the impact of genetic variants on health and diseases. Key to ongoing gNBS pilot studies is the selection of target diseases and associated genes to be included. In this study, we present a comprehensive analysis of seven published gene–disease lists from gNBS studies, evaluating gene–disease count, composition, group proportions, and ClinGen curations of individual disorders. Despite shared selection criteria, we observe substantial variation in total gene count (median 480, range 237–889) and disease group composition. An intersection was identified for 53 genes, primarily inherited metabolic diseases (83%, 44/53). Each study investigated a subset of exclusive gene–disease pairs, and the total number of exclusive gene–disease pairs was positively correlated with the total number of genes included per study. While most pairs receive “Definitive” or “Strong” ClinGen classifications, some are labeled as “Refuted” ( n = 5) or “Disputed” ( n = 28), particularly in genetic cardiac diseases. Importantly, 17%–48% of genes lack ClinGen curation. This study underscores the current absence of consensus recommendations for selection criteria for target diseases for gNBS resulting in diversity in proposed gene–disease pairs, their coupling with gene variations and the use of ClinGen curation. Our findings provide crucial insights into the selection of target diseases and accompanying gene variations for future gNBS program, emphasizing the necessity for ongoing collaboration and discussion about criteria harmonization for panel selection to ensure the screening's objectivity, integrity, and broad acceptance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Human Genetics, Heidelberg University and University Hospital Heidelberg, Heidelberg, Germany.
- Centre for Child and Adolescent Medicine, Division of Child Neurology and Metabolic Medicine, Heidelberg University and University Hospital Heidelberg, Heidelberg, Germany.
- Section of Translational Medical Ethics, National Center for Tumour Diseases, Heidelberg University and University Hospital Heidelberg, Heidelberg, Germany.
ORCID-Profile: Heiko Brennenstuhl
Förderung
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Betzler, I. R., Hempel, M., Mütze, U., Kölker, S., Winkler, E., Dikow, N., Garbade, S. F., Schaaf, C. P., & Brennenstuhl, H. (2024). Comparative analysis of gene and disease selection in genomic newborn screening studies. Journal of Inherited Metabolic Disease, 47(5), 945-970. https://doi.org/10.1002/jimd.12750
Vancouver
Betzler IR, Hempel M, Mütze U, Kölker S, Winkler E, Dikow N, et al. Comparative analysis of gene and disease selection in genomic newborn screening studies. Journal of Inherited Metabolic Disease. 2024;47(5):945-970. doi:10.1002/jimd.12750
BibTeX
@article{Betzler2024,
author = {Betzler, Isabel R and Hempel, Maja and Mütze, Ulrike and Kölker, Stefan and Winkler, Eva and Dikow, Nicola and Garbade, Sven F and Schaaf, Christian P and Brennenstuhl, Heiko},
title = {Comparative analysis of gene and disease selection in genomic newborn screening studies},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
volume = {47},
number = {5},
pages = {945--970},
doi = {10.1002/jimd.12750}
}
EUVIMED